Ace Therapeutics
Preclinical contract research organization offering integrated preclinical R&D services for pharmaceutical, biotechnology, academic, and research institution clients. Services span early-stage research, drug discovery, and preclinical development, including in vitro and in vivo studies, PK/PD, toxicology, biomarker research, assay development, and tailored study design and data analysis.
Industries
Nr. of Employees
medium (51-250)
Ace Therapeutics
Hauppauge, New York, United States
Services
Gene editing, vector construction, molecular and cellular assays, and omics analysis to support foundational studies and target evaluation.
Target discovery and validation, compound screening, in vitro and in vivo pharmacology, and assay development to advance candidate selection.
In vitro studies, in vivo disease models, pharmacokinetic studies, biomarker research, and safety assessment to generate data for development decisions.
Introductions to external clinical CRO partners for programs progressing beyond preclinical research.
Gene editing, vector construction, molecular and cellular assays, and omics analysis to support foundational studies and target evaluation.
Target discovery and validation, compound screening, in vitro and in vivo pharmacology, and assay development to advance candidate selection.
In vitro studies, in vivo disease models, pharmacokinetic studies, biomarker research, and safety assessment to generate data for development decisions.
Introductions to external clinical CRO partners for programs progressing beyond preclinical research.
Expertise Areas
- Preclinical study design and execution
- Disease model development
- Pharmacokinetics and pharmacodynamics
- Toxicology and safety assessment
Key Technologies
- In vitro cellular and molecular assays
- In vivo animal disease models
- Pharmacokinetic / pharmacodynamic assessment
- Toxicology testing